John Holtrop
Papers
1
Total Citations
10
H-Index
1
About
Dr. John Holtrop is a clinician-researcher whose work focuses on the intersection of metabolic surgery, diabetes management, and critical care complications. His most cited case study, "Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy" (2021, 10 citations), provides a critical clinical warning for surgeons and endocrinologists. The paper details a 51-year-old woman with type 2 diabetes who developed euglycemic diabetic ketoacidosis (euDKA) following robotic-assisted sleeve gastrectomy—a rare but dangerous complication linked to SGLT-2 inhibitor use. By documenting her progression from tachycardia on post-operative day 1 to altered mental status on day 2, Holtrop highlights the diagnostic challenge of euDKA, where normal blood glucose levels can mask life-threatening acidosis. This contribution has informed perioperative protocols, emphasizing the need to withhold SGLT-2 inhibitors before bariatric surgery. Though early in his career, Holtrop’s work bridges metabolic medicine and surgical safety, offering actionable insights that help prevent adverse outcomes in a growing population of diabetic patients undergoing weight-loss procedures.
Research Focus
Key Achievements
Top Papers
- 1